The global epilepsy surgery market is booming, projected to reach $2.8B by 2033, driven by advancements in LITT, rising drug-resistant epilepsy cases, and increased awareness. Explore market trends, key players (Duke Health, NeuroPace), and regional insights in this comprehensive analysis.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.